Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -653 | -332 | -942 | -1,181 | -818 |
| Depreciation Amortization | N/A | N/A | 1 | 1 | 1 |
| Other Working Capital | -5 | -53 | -1,293 | -349 | -411 |
| Other Operating Activity | 0 | 0 | 546 | 227 | 227 |
| Operating Cash Flow | $-658 | $-386 | $-1,687 | $-1,301 | $-1,000 |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | N/A | N/A | 884 | 862 | 862 |
| Investing Cash Flow | $N/A | $0 | $884 | $862 | $862 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 590 | 365 | 725 | 275 | 50 |
| Other Financing Activity | 0 | 0 | 175 | 175 | 100 |
| Financing Cash Flow | $590 | $365 | $900 | $450 | $150 |
| Beginning Cash Position | 114 | 114 | 17 | 28 | 17 |
| End Cash Position | 46 | 94 | 114 | 27 | 28 |
| Net Cash Flow | $-68 | $-21 | $97 | $11 | $12 |
| Free Cash Flow | |||||
| Operating Cash Flow | -658 | -386 | -1,687 | -1,301 | -1,000 |
| Free Cash Flow | -658 | -386 | -1,687 | -1,301 | -1,000 |